Evidence map›Paper›PMID 39511312›Full record

ArticleEMBO molecular medicine2024

Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases.

Partho Protim Adhikary, Temilolu Idowu, Zheng Tan, Christopher Hoang, Selina Shanta, Malti Dumbani, Leah Mappalakayil, Bhuwan Awasthi, Marcel Bermudez, January Weiner and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in EMBO molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Partho Protim AdhikaryFaculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-3755-0810
Temilolu IdowuFaculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0003-1583-8562
Zheng TanFaculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.
Christopher HoangFaculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.
Selina ShantaFaculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.
Malti DumbaniInstitute of Pharmacy, Freie Universität of Berlin, Berlin, Germany.
Leah MappalakayilFaculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0009-0009-7418-1215
Bhuwan AwasthiFaculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-2636-510X
Marcel BermudezInstitute of Pharmacy, Freie Universität of Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-7421-3282
January WeinerBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany.
Dieter BeuleBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany.
Gerhard WolberInstitute of Pharmacy, Freie Universität of Berlin, Berlin, Germany.
Brent D G PageFaculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. brent.page@ubc.ca.ORCID http://orcid.org/0000-0002-2101-1329
Sarah HedtrichFaculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. sarah.hedtrich@bih-charite.de.ORCID http://orcid.org/0000-0001-6770-3657

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39511312
PMCPMC11628616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.